alloxan has been researched along with Diabetic Neuropathies in 20 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated whether increases in the duration of hyperglycemia result in the development of corneal lesions in a mouse model of alloxan (AL)- or streptozotocin (STZ)-induced type 1 diabetes." | 7.88 | Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. ( Matsuura, T; Ozaki, K; Terayama, Y, 2018) |
| " We investigated whether increases in the duration of hyperglycemia result in the development of corneal lesions in a mouse model of alloxan (AL)- or streptozotocin (STZ)-induced type 1 diabetes." | 3.88 | Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. ( Matsuura, T; Ozaki, K; Terayama, Y, 2018) |
| "The efficacy of Momordica charantia (MC), Eugenia jambolana (EJ), Tinospora cordifolia (TC) and Mucuna pruriens (MP) was assessed in the prevention of murine alloxan dibetic cataract." | 3.71 | Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. ( Biswas, NR; Grover, JK; Rathi, SS; Vikrant, V, 2002) |
| "Lycopene (4 mg/kg) was administered to the rats in LG once a day for 3 months." | 1.51 | The effects of lycopene on alloxan induced diabetic optic neuropathy. ( Elpeze, B; Icel, A; Icel, E; Karakurt, Y; Keskin Çimen, F; Süleyman, H; Uçak, T, 2019) |
| "Alloxan treatment caused hyperglycemia and reduced boy growth." | 1.29 | Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P. ( Di Giulio, AM; Gorio, A; Lesma, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sherbeeny, NA | 1 |
| Ibrahiem, AT | 1 |
| Ali, HS | 1 |
| Farag, NE | 1 |
| Toraih, EA | 1 |
| Zaitone, SA | 1 |
| Icel, E | 1 |
| Icel, A | 1 |
| Uçak, T | 1 |
| Karakurt, Y | 1 |
| Elpeze, B | 1 |
| Keskin Çimen, F | 1 |
| Süleyman, H | 1 |
| Ozaki, K | 1 |
| Terayama, Y | 1 |
| Matsuura, T | 1 |
| Kara, A | 1 |
| Unal, D | 1 |
| Simsek, N | 1 |
| Yucel, A | 1 |
| Yucel, N | 1 |
| Selli, J | 1 |
| Raafat, K | 1 |
| Aboul-Ela, M | 1 |
| El-Lakany, A | 1 |
| Volchegorskiĭ, IA | 1 |
| Rassokhina, LM | 1 |
| Miroshnichenko, IIu | 1 |
| Thorve, VS | 1 |
| Kshirsagar, AD | 1 |
| Vyawahare, NS | 1 |
| Thakurdesai, PA | 1 |
| Bhandare, AM | 1 |
| Spadella, CT | 1 |
| Lucchesi, AN | 1 |
| Alberti, S | 1 |
| Resende, LA | 1 |
| Rathi, SS | 1 |
| Grover, JK | 1 |
| Vikrant, V | 1 |
| Biswas, NR | 1 |
| Jianbo, L | 1 |
| Chengya, W | 1 |
| Jiawei, C | 1 |
| Xiaolu, L | 1 |
| Zhenqing, F | 1 |
| Hongtai, M | 1 |
| Brown, MR | 1 |
| Dyck, PJ | 1 |
| McClearn, GE | 1 |
| Sima, AA | 1 |
| Powell, HC | 1 |
| Porte, D | 1 |
| Moore, SA | 1 |
| Peterson, RG | 1 |
| Felten, DL | 1 |
| O'Connor, BL | 1 |
| Di Giulio, AM | 2 |
| Lesma, E | 1 |
| Gorio, A | 3 |
| Yildiz, O | 1 |
| Ozata, M | 1 |
| Ozkardeş, A | 1 |
| Deniz, G | 1 |
| Yildirimkaya, M | 1 |
| Corakçi, A | 1 |
| Yardim, M | 1 |
| Gündoğan, MA | 1 |
| Paro, M | 1 |
| Italiano, G | 1 |
| Travagli, RA | 1 |
| Petrelli, L | 1 |
| Zanoni, R | 1 |
| Prosdocimi, M | 1 |
| Fiori, MG | 2 |
| Marini, P | 2 |
| Vitadello, M | 1 |
| Bianchi, R | 1 |
| Triban, C | 2 |
| Tenconi, B | 1 |
| La Croix, R | 1 |
| Mantegazza, P | 1 |
| Cattabeni, F | 1 |
| Guidolin, D | 1 |
| Fabris, M | 1 |
| Schiavinato, A | 1 |
| Donà, M | 1 |
| Bortolami, MC | 1 |
| Di Giamberardino, L | 1 |
| Goto, I | 1 |
| Peters, HA | 1 |
| Shorr, SS | 1 |
| Bloom, FE | 1 |
20 other studies available for alloxan and Diabetic Neuropathies
| Article | Year |
|---|---|
Carbamazepine conquers spinal GAP43 deficiency and sciatic Nav1.5 upregulation in diabetic mice: novel mechanisms in alleviating allodynia and hyperalgesia.
Topics: Alloxan; Animals; Carbamazepine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Mod | 2020 |
The effects of lycopene on alloxan induced diabetic optic neuropathy.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Diabetic | 2019 |
Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes.
Topics: Alloxan; Animals; Cornea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuro | 2018 |
Ultra-structural changes and apoptotic activity in cerebellum of post-menopausal-diabetic rats: a histochemical and ultra-structural study.
Topics: Aging; Alloxan; Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain Edema; Cerebellum; Diabetes | 2014 |
Alloxan-induced diabetic thermal hyperalgesia, prophylaxis and phytotherapeutic effects of Rheum ribes L. in mouse model.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathie | 2021 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; D | 2011 |
H. Spinosa T. Anders ameliorates diabetic neuropathy in Wistar albino rats.
Topics: Acanthaceae; Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Administ | 2012 |
Early pancreas transplant improves motor nerve conduction in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Progression; Glyca | 2012 |
Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts.
Topics: Administration, Oral; Alloxan; Animals; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Di | 2002 |
The role of IGF-1 gene expression abnormality in pathogenesis of diabetic peripheral neuropathy.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophysiology; Evoked | 2002 |
Central and peripheral nervous system complications.
Topics: Alloxan; Animals; Central Nervous System Diseases; Cricetinae; Cricetulus; Diabetic Neuropathies; Di | 1982 |
A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neura | 1980 |
Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
Topics: Alloxan; Animals; Axons; Blood Glucose; Body Weight; Carnitine; Diabetic Neuropathies; Male; Rats; R | 1995 |
Comparison of the effects of aminoguanidine and L-carnitine treatments on somatosensorial evoked potentials in alloxan-diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic N | 1996 |
Cystometric changes in alloxan diabetic rats: evidence for functional and structural correlates of diabetic autonomic neuropathy.
Topics: Alloxan; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuro | 1990 |
Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment.
Topics: Acetylcholinesterase; Alloxan; Animals; Axonal Transport; Diabetes Mellitus, Experimental; Diabetic | 1986 |
Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut.
Topics: Alloxan; Animals; Autonomic Nervous System; Biogenic Monoamines; Diabetes Mellitus, Experimental; Di | 1989 |
Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy.
Topics: Alloxan; Animals; Antibodies, Monoclonal; Axons; Blood Glucose; Body Weight; Diabetes Mellitus, Expe | 1989 |
Serial in vivo determination of motor conduction velocity in tails of allaxanized non-diabetic and diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; El | 1974 |
Fine structure of islet-cell innervation in the pancreas of normal and alloxan-treated rats.
Topics: Alloxan; Animals; Axons; Diabetic Neuropathies; Ganglia, Autonomic; Indicators and Reagents; Iodides | 1970 |